Fritextsökning
Innehållstyper
-
Multiplex Immunofluorescence
New protocol for efficient generation of seven-color, whole slide imaging with ZEISS Axioscan.
-
The Versatile Solution for Quality Management and Data Analysis
Join our ZEISS PiWeb webinar on March 26.
-
Samuel Lagercrantz: ”Hansa och Bioarctic visar styrka – men klarar de nästa steg?”
, kan ta sig vidare och bli mer än one hit wonders.
-
We are expanding our English-language coverage
Over a period of four weeks, one of Life Science Sweden's regular daily newsletters is being published entirely in English. The aim is to meet increasing demand...
-
Fourteen US-based top researchers recruited to Sweden
Sweden has set its sights on America’s top scholars – and it seems to work. By the end of 2025, fourteen leading U.S.-based researchers had already been won ove...
-
Thermo Fisher’s lab in Gothenburg opens
Thermo Fisher’s clinical research business, PPD, is opening its first bioanalytical laboratory in Europe. The company chose Gothenburg for the new facility, whi...
-
How Microscopy Can Help Families Grow
Advanced microscopy solutions can help bypass challenges and natural barriers of conception.
-
Aurevia expert spotlight: 3 questions with our risk management expert
Meet Cristina Albu Barkman, Principal Consultant, and one of Aurevia’s most experienced specialists in medical device risk management. With more than 25 years i...
-
Svenskt biotechbolag tar in 153 miljoner till cancerstudie
One-carbon Therapeutics, ett svenskt biotechbolag med inriktning på svårbehandlad cancer, har tagit in 153 miljoner kronor i en övertecknad investeringsrunda.
-
ISO 13485 Standard Internal Auditing Course
Do you work with medical devices and quality management? Strengthen your expertise with our ISO 13485 Standard Internal Auditing Training — designed to give you...
-
Positive outcome in phase III for Sanofi’s eczema treatment
The antibody amlitelimab shows positive Phase III data as a treatment for atopic dermatitis. France‑based Sanofi now plans to submit global regulatory applicati...
-
International medical graduates leave Sweden in high numbers
Three years after completing their studies, 46 percent of international doctoral students who graduated in the medical field had left the country. This is shown...
-
“The US matters most – even in times of turbulence”
Tariffs, geopolitical uncertainty and rapidly changing trade conditions mean that Swedish life science companies need more routes into global markets – and fast...
-
National cord blood bank resumes collection
The collection of umbilical cord blood is now resuming during planned caesarean sections at Östra Hospital in Gothenburg. The blood remaining in the placenta an...
-
GSK eyes blockbuster potential – plans five new trials
GSK sees blockbuster potential in its experimental drug candidate Mo-rez. Early trial results suggest the treatment may shrink tumours in patients with advanced...
-
Gene therapy restored hearing in children with congenital deafness
Eleven out of twelve children with congenital deafness showed improvements in a study testing Regeneron’s gene therapy for hereditary hearing loss. The U.S. com...
-
Thermo Fisher Expands in Sweden – “We Are Sending a Clear Message”
The American life science giant Thermo Fisher Scientific has inaugurated a new distribution center in Uppsala. “By investing in increasing our capacity as well ...
-
Why Data and AI Skills Are Becoming Critical in Life Science Teams
Life Science organizations are investing heavily in data platforms, digital tools and AI driven solutions. From production and quality to clinical development a...
-
Partner article: Building sponsor oversight for a pivotal Phase III program
OncoZenge is preparing to initiate a pivotal Phase III study for BupiZenge™, a treatment for oral mucositis pain in cancer patients. As the program advances int...
-
ZEISS Connected Quality: One metrology hub
The new product family ZEISS CONNECTED QUALITY is the solution for quick and secure data exchange, quality management and efficient system monitoring.
-
“Access to capital increases when there’s an exit”
It remains a tough environment for biotech companies seeking financing – but there is good reason to hope for improvement ahead. That’s the view of Okee William...
-
New antibody aims to slow kidney damage – “It’s kind of cool”
For 25 years, Marie Jeansson has studied the kidney and its blood vessels. She is now working on developing a drug intended to slow down chronic kidney disease.
-
New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows
Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.
-
Southern Swedish company Aqilion develops drug for eosinophilic esophagitis
When Aqilion began developing a drug for eosinophilic esophagitis, the molecule was classified as an orphan drug. But the prevalence of the disease now appears ...
BREAKING